Experimental ADHD Drugs Aimed at Aggression, Genetic Targets

By |2021-11-11T17:07:48-08:00June 14th, 2017|Brief Bulletins from the Field, We Know Psychiatry|

MIAMI – Medications in development for the treatment of attention-deficit/hyperactivity disorder (ADHD) target specific behaviors, such as impulsive aggression, and genes that involve the glutamatergic network, new research shows. In the first of two studies presented here at the American Society of Clinical Pharmacology (ASCP), researchers reported on improvements in [...]